A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study
EuroIntervention 2015;11:541-548 published online ahead of print August 2014. DOI: 10.4244/EIJY14M08_06
Emanuele Barbato1, MD; Sonja Salinger-Martinovic2, MD; Dragan Sagic3, MD; Branko Beleslin4, MD; Mathias Vrolix5, MD; Aleksandar N. Neskovic6, MD; Nikola Jagic7, MD; Stefan Verheye8, MD; Zlatko Mehmedbegovic4, MD; William Wijns1*, MD
1. Cardiovascular Center Aalst, Aalst, Belgium; 2. Clinical Centre Nis, Nis, Serbia; 3. Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia; 4. Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 5. AZ St J
Aims: To report the six-month angiographic and two-year clinical outcome data from the first-in-man study with the Ultimaster DES, a thin-strut cobalt-chromium sirolimus-eluting stent (SE